Explore the details of the Novartis Pharmaceuticals Corporation V. Msn Pharmaceuticals Inc. case under case number 1:24-cv-01193 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-01193
Filing Date
Oct 24, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Astex Therapeutics Ltd. -
MSN Laboratories Pvt. Ltd. -
Novartis Pharmaceuticals Corporation -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US9416136B2
-US8962630B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 24, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (oam) (Entered: 10/24/2024)PACER Document
Oct 24, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,962,630; 9,416,136. (oam) (Entered: 10/24/2024)PACER Document
Oct 24, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/10/2024. Date of Expiration of Patent:See Attached.Thirty Month Stay Deadline: 3/10/2027. (oam) (Entered: 10/24/2024)PACER Document
Oct 24, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 10/24/2024)PACER Document
Oct 24, 2024COMPLAINT for PATENT INFRIGEMENT filed against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. ( Filing fee $ 405, receipt number ADEDC-4531894.) - filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(oam) (Entered: 10/24/2024)PACER Document
Oct 24, 2024Summons Issued as to MSN Laboratories Pvt. Ltd. on 10/23/2024; MSN Pharmaceuticals Inc. on 10/23/2024. (Attachments: # 1 Summons Issued)(oam) (Entered: 10/24/2024)PACER Document
Oct 24, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka America, Inc., Other Affiliate Otsuka Holdings Co., Ltd., Other Affiliate Otsuka Pharmaceutical Co., Ltd. for Astex Therapeutics Ltd. filed by Astex Therapeutics Ltd. (oam) (Entered: 10/24/2024)PACER Document
Oct 24, 2024COMPLAINT for PATENT INFRIGEMENT filed against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. ( Filing fee $ 405, receipt number ADEDC-4531894.) - filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(oam) (Entered: 10/24/2024)Attachment
Oct 24, 2024COMPLAINT for PATENT INFRIGEMENT filed against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. ( Filing fee $ 405, receipt number ADEDC-4531894.) - filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(oam) (Entered: 10/24/2024)Attachment